Effectiveness and Outcome of Uterine Embolization with Methotrexate in Treatment of Scar Ectopic PRE

Introduction Background: Scar ectopic pregnancy is the most uncommon type of ectopic pregnancy; however, it is becoming more common across the world. Cesarean scar pregnancy (CSP) could lead to severe complications including excessive hemorrhage, shock and uterine rupture with the potential necessity for hysterectomy.

Method(s) Methodology: This is retrospective study electronic medical record review that was conducted among patients with scar ectopic pregnancy. The data were collected for CSP patients who admitted for receiving treatment in prince sultan military medical city from first month in 2017 until first month of 2022. Three treatment strategies were compared in this study including uterine embolization intervention, methotrexate, and KCL. The serum levels of β-human chorionic gonadotropin (β-HCG) were measured.

Result(s): A total of 29 females with scar ectopic pregnancy undergone methotrexate alone, methotrexate with uterine embolization, or methotrexate with KCL. There is significant reduction in hormone level after intervention especially at the fourth postintervention assessment (after 3 weeks).

Conclusion(s): The study showed no significant difference between different treatment strategies for CSP with none to low complications associated with each treatment.

Publication History

Article published online:
09 February 2023